NAFLD Fibrosis Score – Is it ready for wider use in clinical practice and for clinical trials?
dc.contributor.author | Gawrieh, Samer | |
dc.contributor.author | Chalasani, Naga | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-05-02T07:14:47Z | |
dc.date.available | 2025-05-02T07:14:47Z | |
dc.date.issued | 2013 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Gawrieh S, Chalasani N. NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?. Gastroenterology. 2013;145(4):717-719. doi:10.1053/j.gastro.2013.08.025 | |
dc.identifier.uri | https://hdl.handle.net/1805/47623 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1053/j.gastro.2013.08.025 | |
dc.relation.journal | Gastroenterology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Fatty liver | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Non-alcoholic fatty liver disease | |
dc.title | NAFLD Fibrosis Score – Is it ready for wider use in clinical practice and for clinical trials? | |
dc.type | Article |